Silk Road Medical Inc. (SILK) Misses Q3 EPS by 3c, Revenues Beat

Silk Road Medical Inc. (NASDAQ: SILK) reported Q3 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $20.1 million versus the consensus estimate of $19.59 million.

“We had a strong third quarter in which our revenues grew 18% year over year. Our patient first culture and unwavering commitment to reduce stroke risk are evidenced by our recent milestone of 25,000 cumulative procedures,” said Erica Rogers, President and Chief Executive Officer of Silk Road Medical. “We are continuing to make meaningful investments in our team and our strategic priorities, paving the way for the bright future ahead of us.”

For earnings history and earnings-related data on Silk Road Medical Inc. (SILK) click here.

You May Also Be Interested In

• Citi agrees to acquire rewards platform Kard Financial
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c